MCL-1
|
1q21.2 |
Anti-apoptotic |
Apoptosis resistance, disease progression, and shorter OS |
[35,38] |
CSK1B
|
1q21.3 |
Cell division |
Regulation of the p27 proteasome degradation |
[39,40] |
IL6R
|
1q21.3 |
IL6 regulator |
Increased IL6 sensitivity and hyper-activation of the STAT3 pathway |
[34,41] |
ILF2
|
1q21.3 |
mRNA stability, mRNA post-transcriptional regulation, and in mitotic control. |
Promotes tolerance of genomic instability, enhancing MM cell survival and drug resistance |
[36,42,43] |
BCL9
|
1q21.2 |
T
ranscriptional co-activator of the Wnt/β-catenin pathway
|
Promotes cell proliferation? |
[44,45] |